Quality of Life with Defibrillator Therapy or Amiodarone in Heart Failure | Zendy

Daniel B. Mark | Zendy; Kevin J. Anstrom | Zendy; Jie Sun | Zendy; Nancy E. ClappChanning | Zendy; Anastasios A. Tsiatis | Zendy; Linda DavidsonRay | Zendy; Kerry L. Lee | Zendy; Gust H. Bardy | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Quality of Life with Defibrillator Therapy or Amiodarone in Heart Failure

Author(s) -

Daniel B. Mark,

Kevin J. Anstrom,

Jie Sun,

Nancy E. ClappChanning,

Anastasios A. Tsiatis,

Linda DavidsonRay,

Kerry L. Lee,

Gust H. Bardy

Publication year - 2008

Publication title -

new england journal of medicine

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 19.889

H-Index - 1030

eISSN - 1533-4406

pISSN - 0028-4793

DOI - 10.1056/nejmoa0706719

Subject(s) - medicine , amiodarone , implantable cardioverter defibrillator , heart failure , cardiology , quality of life (healthcare) , longevity , sudden cardiac death , sudden death , intensive care medicine , atrial fibrillation , gerontology , nursing

Implantable cardioverter-defibrillator (ICD) therapy significantly prolongs life in patients at increased risk for sudden death from depressed left ventricular function. However, whether this increased longevity is accompanied by deterioration in the quality of life is unclear.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research